Baxter International Inc.
BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care productā¦ read more
Healthcare
Medical Instruments & Supplies
44 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$19.28
Price+0.89%
$0.17
1Y
Price
Market Cap
$9.910b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+14.7%
EBITDA Margin-1.6%
Net Profit Margin+4.4%
Free Cash Flow Margin+14.7%
EBITDA Margin-1.6%
Net Profit Margin+4.4%
Free Cash Flow MarginRevenue
$11.023b
+3.6%
1y CAGR+3.1%
3y CAGR-2.0%
5y CAGREarnings
-$341m
+47.5%
1y CAGR+44.1%
3y CAGR-39.3%
5y CAGREPS
-$0.66
+48.0%
1y CAGR+44.0%
3y CAGR-39.7%
5y CAGRBook Value
$7.214b
$21.067b
Assets$13.853b
Liabilities$9.712b
DebtDebt to Assets
46.1%
9.5x
Debt to EBITDAFree Cash Flow
$230m
-58.9%
1y CAGR+2.8%
3y CAGR-13.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company